ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis

ClinicalTrials.gov ID: NCT05071664

Public ClinicalTrials.gov record NCT05071664. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 3:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Multicenter, Randomized, Double-blind Study Evaluating the Efficacy and Safety of Subcutaneously Administered Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis

Study identification

NCT ID
NCT05071664
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Janssen Research & Development, LLC
Industry
Enrollment
91 participants

Conditions and interventions

Interventions

  • Golimumab Drug
  • Guselkumab Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 24, 2021
Primary completion
May 13, 2024
Completion
Aug 5, 2024
Last update posted
Apr 12, 2026

2021 – 2024

United States locations

U.S. sites
20
U.S. states
10
U.S. cities
19
Facility City State ZIP Site status
Arizona Arthritis and Rheumatology Research PLLC Phoenix Arizona 85032
Arizona Arthritis and Rheumatology Research PLLC 1 Phoenix Arizona 85037
Unity Health-White County Medical Center Searcy Arkansas 72143
HARAC Research Corp Avon Park Florida 33825
Bay Pines VA Healthcare System Bay Pines Florida 33744
Omega Research Consultants DeBary Florida 32713
South Coast Research Center Miami Florida 33136
Advanced Clinical Research of Orlando Ocoee Florida 34761
Millennium Research Ormond Beach Florida 32174
Atlanta Research Center for Rheumatology Marietta Georgia 30060
Great Lakes Center of Rheumatology Lansing Michigan 48911
Clinvest Springfield Missouri 65807
NYU Langone Ambulatory Care Brooklyn Heights Brooklyn New York 11201
NYU School of Medicine New York New York 10016
University of Rochester Rochester New York 14642
Jacobi Medical Center The Bronx New York 10461
STAT Research, Inc. Vandalia Ohio 45377
Trinity Universal Research Associates, LLC Plano Texas 75024
DM Clinical Research Tomball Texas 77375
Swedish Medical Center Seattle Washington 98122

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05071664, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 12, 2026 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05071664 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →